Effect of Delayed-Release Bile Acid on Insulin Sensitivity, Gastric Emptying and Body Weight in Overweight or Obese Patients With Type 2 Diabetes Mellitus
Phase of Trial: Phase II
Latest Information Update: 16 Nov 2017
At a glance
- Drugs Taurocholic acid (Primary)
- Indications Obesity; Type 2 diabetes mellitus
- Focus Therapeutic Use
- 09 Nov 2017 Planned End Date changed from 1 Jul 2017 to 1 Jul 2018.
- 10 Jun 2017 Biomarkers information updated
- 14 Oct 2016 Status changed from not yet recruiting to recruiting.